cancel as their patents expire...$2b to start again - couldnt they just do that without a t/o? I agree that cancellations occur but I do not think this type of premium would be paid just to cancel new tech and IP imo.
pfizer considers t/o of agila specialties, page-11
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.001(20.0%) |
Mkt cap ! $9.507M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $2.635K | 1.045M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 57 | 93538418 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 60456317 | 21 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| AVE (ASX) Chart |